News of the WeekGene Therapy

RAC's Advice: Proceed With Caution

Science  13 Dec 2002:
Vol. 298, Issue 5601, pp. 2113-2115
DOI: 10.1126/science.298.5601.2113

You are currently viewing the summary.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Summary

BETHESDA, MARYLAND-- The cancer that appeared earlier this year in a patient who took part in a French gene therapy trial appears to have been caused by a rare combination of factors, a panel of experts concluded at a meeting here last week. The risk of a second occurrence seems sufficiently remote, the panel agreed, that this trial and others like it should go forward.

Related Content